摘要
1. HIF-1α pathway: role, regulation and intervention for cancer therapy Acta Pharm Sin B 2015;5:378-389 (Georgina N. Masoud, Wei Li).2. Mechanisms of resistance to EGFR tyrosine kinase inhibitors Acta Pharm Sin B 2015;5: 390-401(Lihua Huang, Liwu Fu).3. Cancer metastases: challenges and opportunities Acta Pharm Sin B 2015;5: 402-418 (XiangmingGuan).4. Insoluble drug delivery strategies: review of recent advances and business prospects Acta PharmSin B 2015;5: 442-453 (Sandeep Kalepu, VijaykumarNekkanti).
